Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Kv7-specific activators hyperpolarize resting membrane potential and modulate human iPSC-derived sensory neuron excitability

Open access
Estacion, Mark, Liu, Shujun, Cheng, Xiaoyang, Dib-Hajj, Sulayman, Waxman, Stephen G. · 2023 · Frontiers in Pharmacology

Abstract

Chronic pain is highly prevalent and remains a significant unmet global medical need. As part of a search for modulatory genes that confer pain resilience, we have studied two family cohorts where one individual reported much less pain than other family members that share the same pathogenic gain-of-function Nav1.7 mutation that confers hyperexcitability on pain-signaling dorsal root ganglion (DRG) neurons. In each of these kindreds, the pain-resilient individual carried a gain-of-function variant in Kv7.2 or Kv7.3, two potassium channels that stabilize membrane potential and reduce excitability. Our observation in this molecular genetic study that these gain-of-function Kv7.2 and 7.3 variants reduce DRG neuron excitability suggests that agents that activate or open Kv7 channels should attenuate sensory neuron firing. In the present study, we assess the effects on sensory neuron excitability of three Kv7 modulators—retigabine (Kv7.2 thru Kv7.5 activator), ICA-110381 (Kv7.2/Kv7.3 specific activator), and as a comparator ML277 (Kv7.1 specific activator)—in a “human-pain-in-a-dish” model (human iPSC-derived sensory neurons, iPSC-SN). Multi-electrode-array (MEA) recordings demonstrated inhibition of firing with retigabine and ICA-110381 (but not with ML277), with the concentration-response curve indicating that retigabine can achieve a 50% reduction of firing with sub-micromolar concentrations. Current-clamp recording demonstrated that retigabine hyperpolarized iPSC-SN resting potential and increased threshold. This study implicates Kv7.2/Kv7.3 channels as effective modulators of sensory neuron excitability, and suggest that compounds that specifically target Kv7.2/Kv7.3 currents in sensory neurons, including human sensory neurons, might provide an effective approach toward pain relief.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2023.1138556

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Retigabine reduces firing of IPSC-SNs in a dose-dependent manner. Spontaneous spiking activity of human iPSC-derived sensory neurons (clone 303) plated into the wells of a 48-well MEA plate. (A) The Log10 count of total spikes observed for a 10 min recording period is displayed with a symbol for each well. The panel illustrates the temperature response of the MEA activity and gives an indication of the well-to-well variability. The data represent the same plate recorded at the indicated temperatures in centigrade. (B) The panel shows the Log10 counts at 37°C that after group balancing, the dose-response relationship of the inhibition by retigabine is well determined with an IC50 of 1.7 µM. Retigabine is clearly effective at reducing spontaneous activity of the human iPSC-derived sensory neurons. (C) A display of the activity from a selected well that was exposed to 1 µM retigabine. In the pre-treatment recording, 9 of the 16 electrodes from well B7 detected spiking activity and the number of spikes, waveform of the spikes, and a raster plot of the timing of the spikes is shown. After exposure to 1 µM retigabine, 8 electrodes still recorded spiking activity.
FIGURE 1 Retigabine reduces firing of IPSC-SNs in a dose-dependent manner. Spontaneous spiking activity of human iPSC-derived sensory neurons (clone 303) plated into the wells of a 48-well MEA plate. (A) The Log10 count of total spikes observed for a 10 min recording period is displayed with a symbol for each well. The panel illustrates the temperature response of the MEA activity and gives an indication of the well-to-well variability. The data represent the same plate recorded at the indicated temperatures in centigrade. (B) The panel shows the Log10 counts at 37°C that after group balancing, the dose-response relationship of the inhibition by retigabine is well determined with an IC50 of 1.7 µM. Retigabine is clearly effective at reducing spontaneous activity of the human iPSC-derived sensory neurons. (C) A display of the activity from a selected well that was exposed to 1 µM retigabine. In the pre-treatment recording, 9 of the 16 electrodes from well B7 detected spiking activity and the number of spikes, waveform of the spikes, and a raster plot of the timing of the spikes is shown. After exposure to 1 µM retigabine, 8 electrodes still recorded spiking activity.CC BY · PubMed Central
FIGURE 2 Relative response of Kv7 selective compounds. Spontaneous spiking activity of human iPSC-derived sensory neurons (clone 129) plated into the wells of a 48-well MEA plate. (A) The Log10 count of total spikes per well observed for a 10 min recording period at 37°C is displayed with a symbol for each well. The data groupings showed relatively equal means and SEM before treatment with the indicated compounds all at the same concentration of 3 µM. Both retigabine and ICA-110381 significantly reduced spontaneous spiking activity (p < 0.001) while ML277 showed a small but not significant reduction of activity (p = 0.54) compared to vehicle control. (B) The overall well responses were mirrored at the level of individual electrodes which likely represent the activity of individual sensory neurons as shown in the before and after plots.
FIGURE 2 Relative response of Kv7 selective compounds. Spontaneous spiking activity of human iPSC-derived sensory neurons (clone 129) plated into the wells of a 48-well MEA plate. (A) The Log10 count of total spikes per well observed for a 10 min recording period at 37°C is displayed with a symbol for each well. The data groupings showed relatively equal means and SEM before treatment with the indicated compounds all at the same concentration of 3 µM. Both retigabine and ICA-110381 significantly reduced spontaneous spiking activity (p < 0.001) while ML277 showed a small but not significant reduction of activity (p = 0.54) compared to vehicle control. (B) The overall well responses were mirrored at the level of individual electrodes which likely represent the activity of individual sensory neurons as shown in the before and after plots.CC BY · PubMed Central
FIGURE 3 ICA-110381 a Kv7.2/Kv7.3 specific activator, attenuates firing of iPSC-SNs, while ML277, a Kv7.1 specific activator, does not Spontaneous spiking activity of human iPSC-derived sensory neurons (clone 129) plated into the wells of a 48-well MEA plate. (A) The panel shows the Log10 counts at 37°C that after group balancing, the dose-response relationship of the inhibition by ICA-110381 is well determined with an IC50 of 2.0 µM. ICA-110381 is clearly effective at reducing spontaneous activity of the human iPSC-derived sensory neurons. Spontaneous spiking activity of human iPSC-derived sensory neurons (clone 129) plated into the wells of a 48-well MEA plate. (B) The panel shows the Log10 counts at 37°C for balanced groups indicate that the inhibitory effect of ML277 at the chosen concentrations is minimal. The attempt to fit an inhibitory dose-response curve failed and thus is not shown.
FIGURE 3 ICA-110381 a Kv7.2/Kv7.3 specific activator, attenuates firing of iPSC-SNs, while ML277, a Kv7.1 specific activator, does not Spontaneous spiking activity of human iPSC-derived sensory neurons (clone 129) plated into the wells of a 48-well MEA plate. (A) The panel shows the Log10 counts at 37°C that after group balancing, the dose-response relationship of the inhibition by ICA-110381 is well determined with an IC50 of 2.0 µM. ICA-110381 is clearly effective at reducing spontaneous activity of the human iPSC-derived sensory neurons. Spontaneous spiking activity of human iPSC-derived sensory neurons (clone 129) plated into the wells of a 48-well MEA plate. (B) The panel shows the Log10 counts at 37°C for balanced groups indicate that the inhibitory effect of ML277 at the chosen concentrations is minimal. The attempt to fit an inhibitory dose-response curve failed and thus is not shown.CC BY · PubMed Central
FIGURE 4 Retigabine hyperpolarizes RMP and increases current threshold (A) Example traces showing the hyperpolarizing shift of RMP in response to application of 10 µM retigabine (blue trace). This cell showed a stable RMP of −49 mV during baseline period and a clear shift of RMP to −63 mV in response to retigabine. In a different cell, 0.1% DMSO vehicle control caused little or no change of RMP (green trace). (B) Example traces from a representative cell which first fired a spike at 80 pA from a RMP of −61 mV during baseline period and then the RMP shifted to −69 mV in response to 10 µM retigabine and increased the threshold to 115 pA. (C) Combined before and after shifts of RMP in response to 10 µM retigabine. Nearly every cell showed a hyperpolarization of RMP and showed a significant average hyperpolarization of 6.3 mV (n = 10). (D) Combined before and after shifts of RMP in response to vehicle control 0.1% DMSO. The shifts were small and variable and the 1 mV depolarizing shift of RMP was not significant (n = 10). (E) Combined before and after shifts of threshold in response to 10 µM retigabine. Every cell showed an increase of current needed to elicit a first spike with a statistically significant average increase of 31 pA (n = 10). (F) Combined before and after shifts of threshold in response to vehicle control 0.1% DMSO. The shifts were small and variable and the 5 pA reduction of threshold was not significant (n = 10).
FIGURE 4 Retigabine hyperpolarizes RMP and increases current threshold (A) Example traces showing the hyperpolarizing shift of RMP in response to application of 10 µM retigabine (blue trace). This cell showed a stable RMP of −49 mV during baseline period and a clear shift of RMP to −63 mV in response to retigabine. In a different cell, 0.1% DMSO vehicle control caused little or no change of RMP (green trace). (B) Example traces from a representative cell which first fired a spike at 80 pA from a RMP of −61 mV during baseline period and then the RMP shifted to −69 mV in response to 10 µM retigabine and increased the threshold to 115 pA. (C) Combined before and after shifts of RMP in response to 10 µM retigabine. Nearly every cell showed a hyperpolarization of RMP and showed a significant average hyperpolarization of 6.3 mV (n = 10). (D) Combined before and after shifts of RMP in response to vehicle control 0.1% DMSO. The shifts were small and variable and the 1 mV depolarizing shift of RMP was not significant (n = 10). (E) Combined before and after shifts of threshold in response to 10 µM retigabine. Every cell showed an increase of current needed to elicit a first spike with a statistically significant average increase of 31 pA (n = 10). (F) Combined before and after shifts of threshold in response to vehicle control 0.1% DMSO. The shifts were small and variable and the 5 pA reduction of threshold was not significant (n = 10).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 14

Metadata

Authors
Estacion, M., Liu, S., Cheng, X., Dib-Hajj, S., & Waxman, S. G.
Affiliations
Yale University (US)
Corresponding author
Waxman, Stephen G.
Venue
Frontiers in Pharmacology
Published
2023-02-27
Volume
14
Pages
1138556-1138556
ISSN
1663-9812 (ISSN-L)
OpenAlex
W4322506649
Cited by
11
References
48
Citations by year
2026: 5 · 2025: 5 · 2024: 1
FWCI
0.98
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Veterans Affairs
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
Keywords
Kv7.2, Kv7.3, Kv7 channels, retigabine, sensory neuron excitability, dorsal root ganglion neurons, resting membrane potential, hyperpolarization, chronic pain, pain resilience, potassium channel modulators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Kv7-specific activators hyperpolarize resting membrane potential and modulate human iPSC-derived sensory neuron excitability. https://app.cochat.ai/papers/10.3389/fphar.2023.1138556
The paper
Estacion, M., Liu, S., Cheng, X., Dib-Hajj, S., & Waxman, S. G. (2023). Kv7-specific activators hyperpolarize resting membrane potential and modulate human iPSC-derived sensory neuron excitability. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2023.1138556

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.